Correlation of phosphorylated HER2 with clinicopathological characteristics and efficacy of trastuzumab treatment for breast cancer. - Concepedia

Concepedia

Publication | Closed Access

Correlation of phosphorylated HER2 with clinicopathological characteristics and efficacy of trastuzumab treatment for breast cancer.

16

Citations

0

References

2013

Year

Snježana Ramić, Ksenija Asić, Melita Perić Balja, Frane Paić, Vesna Benković, Fabijan Knežević

Abstract

Positive expression of pHER2 may yield additional information regarding the poor prognosis of BC and could be used for pre-selection of patients with HER2-overexpressing BC displaying resistance to trastuzumab treatment.